Evidence map›Paper›PMID 19484266›Full record

ArticleCell and tissue research2009

Differential effects of Pyk2 and FAK on the hypertrophic response of cardiac myocytes.

Emmanuel B Menashi, Joseph C Loftus

Open access · greenAbstract read
In one paragraph

Article in Cell and tissue research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Emmanuel B MenashiDepartment of Biochemistry and Molecular Biology, Mayo Clinic Arizona, Scottsdale, 85259, USA.
Joseph C Loftus
Mayo Clinic in Arizona · US

Funding

Role of Integrins in Cardiac Myocyte FunctionR01HL067938 · NHLBI · MAYO CLINIC COLL OF MED, MAYO CLINIC AZ · PI LOFTUS, JOSEPH C · 2001 to 2004
$1.1M
NHLBI NIH HHS HL67938NHLBI NIH HHS R01 HL067938
6 · The paper itself

Abstract

The related cytoplasmic non-receptor tyrosine kinases Pyk2 (proline-rich tyrosine kinase 2) and FAK (focal adhesion kinase) have been implicated in phenylephrine-induced G-protein-coupled receptor-mediated signaling mechanisms leading to cardiomyocyte hypertrophy. We report that, in phenylephrine-stimulated neonatal rat ventricular myocytes (NRVM), Pyk2 augments expression of the hypertrophic marker atrial natriuretic factor (ANF) but reduces cytoskeletal organization and cell spreading. In contrast, FAK attenuates ANF production but does not alter cytoskeletal organization and cell spreading. Pyk2 and FAK exhibit differential localization in both unstimulated and phenylephrine-stimulated myocytes. Pyk2 catalytic activity is required for Pyk2 to augment ANF secretion but is not necessary to reduce cell spreading. Pyk2 autophosphorylation is required but not sufficient for Pyk2 to augment ANF secretion. Expression of the Pyk2 FERM domain as an autonomous fragment inhibits phenylephrine-mediated ANF secretion and reduces cell spreading. In addition, expression of the Pyk2 FERM domain inhibits the ability of Pyk2 to augment ANF secretion; this is correlated with reduced Pyk2 autophosphorylation. These data indicate that Pyk2 and FAK have different roles and occupy different positions in signaling pathways leading to the development of cardiomyocyte hypertrophy.

Indexed as

AnimalsAtrial Natriuretic FactorCardiac MyosinsCardiomegalyCardiotonic AgentsCell MovementCells, CulturedCytoskeletonFocal Adhesion Kinase 1Focal Adhesion Kinase 2Myocytes, CardiacMyosin Light ChainsPhenylephrinePhosphorylationRatsRats, Sprague-DawleyAtrial Natriuretic FactorCardiac MyosinsCardiotonic AgentsFocal Adhesion Kinase 1Focal Adhesion Kinase 2myosin light chain 2Myosin Light ChainsPhenylephrinePtk2 protein, rat

Identifiers

PMID19484266
PMCPMC3934419
OpenAlexW2020753936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.